Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 1H-Indole-5-carboxylic acid, 3-[(4R)-7-chloro-10-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-3,4-dihy | 2131184-57-9 | 98.5% | 712.66 | 25 MG
SDP

Supplier:  Medchemexpress LLC 25MGHY112859

Encompass_Preferred

VU661013 is a potent and selective MCL-1 inhibitor. It exhibits a Ki of 97±30 pM to human MCL-1 in a TR-FRET assay by displacing a fluorescently labeled peptide derived from the pro-apoptotic protein BAK. However, VU661013 does not significantly inhibit BCL-xL (Ki>40 μM) or BCL-2 (Ki=0.73 μM).

  • VU661013 is a novel, potent, selective MCL-1 inhibitor that de-stabilizes BIM/MCL-1 association.
  • It leads to apoptosis in AML.
  • It is active in Venetoclax-resistant cells and patient derived xenografts.
  • Treatment with VU661013 results in a dose-dependent decrease in tumor burden in disseminated human AML.

Catalog No. 50-004-39263


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.